Relations of serum adipocyte fatty acid binding protein to sex hormone and lipoproteins in patients with polycystic ovary syndrome

National Medical Journal of China

Volumn 86, Issue 45, 2006, Pages 3186-3189

  Hu, Wei Hong ^a   Qiao, Jie ^a   Li, Rong ^a   Wang, Li Na ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Fatty acids; Lipoprotein; Polycystic ovary syndrome; Testosterone

Indexed keywords

ADIPOCYTE FATTY ACID BINDING PROTEIN; ANDROGEN; ANDROSTENEDIONE; ESTRADIOL; FATTY ACID BINDING PROTEIN; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PROLACTIN; SEX HORMONE; TESTOSTERONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BODY MASS; CHEMOLUMINESCENCE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; LIPID METABOLISM; LUTEINIZING HORMONE BLOOD LEVEL; OVARY POLYCYSTIC DISEASE; PROLACTIN BLOOD LEVEL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RADIOIMMUNOASSAY; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UNIVARIATE ANALYSIS;

ADULT; CHOLESTEROL, HDL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; LIPIDS; LIPOPROTEINS, HDL; POLYCYSTIC OVARY SYNDROME; TESTOSTERONE;

EID: 33847353685     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Chinese source.
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril,2004, 81:19-22.
3. Coe NR, Bernlohr DA. Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim Biophys Acta, 1998,1391: 287-306.
4. Zimmerman AW, Veerkamp JH. New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci, 2002,59: 1096-1116.
5. Jolly CA, Murphy EJ, Schroeder F. Differential influence of rat liver fatty acid binding protein isoforms on phospholipid fatty acid composition: phosphatidic acid biosynthesis and phospholipid fatty acid remodeling. Biochim Biophys Acta, 1998,1390: 258-268.
6. Scheja L, Makowski L, Uysal KT, et al. Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. Diabetes, 1999,48: 1987-1994.
7. Coe NR, Simpson MA, Bernlohr DA. Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res, 1999, 40: 967-972.
8. Fu Y, Luo N, Lopes-Virella MF, et al. The adipocyte lipid binding protein (ALBP/ aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis, 2002,165: 259-269.
9. Wolfrum C, Borrmann CM, Borchers T, et al. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha- and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc Natl Acad Sci. USA, 2001,98: 2323-2328.
10. Helledie T, Antonius M, Sorensen RV, et al. Lipid-binding proteins modulate ligand dependent trans-activation by peroxisome proliferator-activated receptors and localize to the nucleus as well as the cytoplasm. J Lipid Res, 2000, 41:1740-1751.
11. Gregoire FM, CM Smas, HS Sul. Understanding adipocyte differentiation. Physiol Res, 1998, 78: 783-809.
12. Bernlohr DA, Simpson MA, Hertzel AV, et al. Intracellular lipid-binding proteins and their genes. Annu Rev Nutr, 1997, 17: 277-303.
13. Reese-Wagoner A, Thompson J, Banaszak L. Structural properties of the adipocyte lipid binding protein. Biochim Biophys Acta, 1999, 1441: 106-116.
14. Mandrup S, Lane MD. Regulating adipogenesis. J Biol Chem, 1997, 272: 5367-5370.
15. Morrison RF, Farmer SR. Insights into the transcriptional control of adipocyte differentiation. J Cell Biochem, 1999, 32/33 (Suppl): 59-67.
16. Jiang C, Ting AT, Seed B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature, 1998, 391: 82-86.
17. Ricote M, Huang J, Fajas L, et al. Expression of the peroxisome proliferator-activated receptor (PPAR) in human atherosclerosis and regulation in macrophages by colony stimu-lating factors and oxidized low density lipoprotein. Proc Natl Acad Sci USA, 1998, 95: 7614-7619.
18. Sun L, Nicholson AC, Hajjar DP, et al. Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line. J Lipid Res, 2003, 44:1877-1886.
19. Pelton PD, Zhou L, Demarest KT, et al. PPAR activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. Biochem Biophys Res Commun, 1999, 261: 456-458.
20. Fu Y, Luo N, Lopes-Virella MF. Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. J Lipid Res, 2000, 41: 2017-2023.
21. Hotamisligil GS, Johnson RS, Distel RJ, et al. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science, 1996,274: 1377-1379.
22. Makowski L, Boord JB, Maeda K, et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med, 2001,7: 699-705.
23. Boord JB, Maeda K, Makowski L, et al. Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler Thromb Vasc Biol, 2002, 22: 1686-1691.
24. Aimin X, Yu W, Jian Yu X, et al. Adipocyte Fatty Acid-Binding Protein Is a Plasma Biomarker Closely Associated with Obesity and Metabolic Syndrome. Clin Chem, 2006, 52: 405-413.